DE69024363D1 - Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung - Google Patents

Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung

Info

Publication number
DE69024363D1
DE69024363D1 DE69024363T DE69024363T DE69024363D1 DE 69024363 D1 DE69024363 D1 DE 69024363D1 DE 69024363 T DE69024363 T DE 69024363T DE 69024363 T DE69024363 T DE 69024363T DE 69024363 D1 DE69024363 D1 DE 69024363D1
Authority
DE
Germany
Prior art keywords
hydrogel particles
edmable
production
macroporous hydrogel
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69024363T
Other languages
English (en)
Other versions
DE69024363T2 (de
Inventor
Robert Eury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Publication of DE69024363D1 publication Critical patent/DE69024363D1/de
Application granted granted Critical
Publication of DE69024363T2 publication Critical patent/DE69024363T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DE69024363T 1989-10-03 1990-09-28 Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung Expired - Fee Related DE69024363T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41656789A 1989-10-03 1989-10-03
PCT/US1990/005564 WO1991004732A1 (en) 1989-10-03 1990-09-28 Erodible macroporous hydrogel particles and preparation thereof

Publications (2)

Publication Number Publication Date
DE69024363D1 true DE69024363D1 (de) 1996-02-01
DE69024363T2 DE69024363T2 (de) 1996-07-04

Family

ID=23650468

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024363T Expired - Fee Related DE69024363T2 (de) 1989-10-03 1990-09-28 Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung

Country Status (11)

Country Link
EP (1) EP0494996B1 (de)
JP (1) JP2980978B2 (de)
KR (1) KR920703016A (de)
AT (1) ATE131726T1 (de)
AU (1) AU646414B2 (de)
CA (1) CA2066594A1 (de)
DE (1) DE69024363T2 (de)
DK (1) DK0494996T3 (de)
ES (1) ES2083467T3 (de)
HK (1) HK1007109A1 (de)
WO (1) WO1991004732A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130320C (zh) * 1995-07-28 2003-12-10 纳幕尔杜邦公司 负载有浮游植物所需微量营养元素的水漂浮颗粒材料
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
DE19622355A1 (de) 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
US20030008926A1 (en) * 1997-04-30 2003-01-09 Mcpartland Tor Ant spray containing D-limonene and methods of making and using same
US20020004502A1 (en) 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US6878384B2 (en) * 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
KR101443926B1 (ko) 2006-06-15 2014-10-02 마이크로벤션, 인코포레이티드 팽창성 중합체로 제조된 색전술용 장치
EP2231215B1 (de) 2007-12-21 2019-01-30 MicroVention, Inc. Hydrogelfilamente für den biomedizinischen einsatz
US8668863B2 (en) * 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2015167752A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
CN114384227A (zh) * 2021-06-16 2022-04-22 西安石油大学 一种致密砂岩的准连续溶蚀-胶结作用致密机理测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
DE3789956T2 (de) * 1986-08-15 1994-11-10 Advanced Polymer Systems Inc Polymere trägerzubereitungen, herstellung und verwendung.
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates

Also Published As

Publication number Publication date
CA2066594A1 (en) 1991-04-04
HK1007109A1 (en) 1999-04-01
AU646414B2 (en) 1994-02-24
ES2083467T3 (es) 1996-04-16
ATE131726T1 (de) 1996-01-15
KR920703016A (ko) 1992-12-17
JP2980978B2 (ja) 1999-11-22
EP0494996A1 (de) 1992-07-22
DE69024363T2 (de) 1996-07-04
JPH05500959A (ja) 1993-02-25
WO1991004732A1 (en) 1991-04-18
EP0494996A4 (en) 1992-09-30
DK0494996T3 (da) 1996-03-18
AU6715690A (en) 1991-04-28
EP0494996B1 (de) 1995-12-20

Similar Documents

Publication Publication Date Title
ATE131726T1 (de) Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE3774266D1 (de) Poroese polymerperlen zur wirkstoffabgabe.
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
DK164256C (da) Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
FI965203A0 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
BR8606003A (pt) Composicoes de liberacao prolongada compreendendo eteres de hidroxipropil celulose
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
PT78434B (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
DE69914320D1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
EP0145210A3 (de) Mit für biologisch aktiven Glasrohstoffen beschichtete Stützteilchen
NO953995L (no) Ionenolymere som anthelmintica i dyr
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ES2060791T3 (es) Composiciones cationicas para aplicacion topica.
EP0475383A3 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
ES513422A0 (es) Procedimiento para la obtencion de un preparado medicamentoso de accion retardada que contiene un polimero hidrofilo de celulosa
ATE236621T1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
SE9604124D0 (sv) Compact member, method of manufacturing and use thereof
DE3775012D1 (de) Oberflaechenaktives mittel und verfahren zur dessen herstellung.
ES2086026T3 (es) Farmaco con efecto antineoplasico que contiene como sustancia activa (2-(n-metil-piperidino)-etil)-fosfato de octadecilo y procedimiento para su preparacion.
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
HUT59011A (en) Process for producing composition, and its active ingredient, suitable for inactivating or removing harmful compounds in blood and other extracellular liquids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee